Document Detail

Killing and mutation of human lymphoblast cells by aflatoxin B1: evidence for an inducible repair response.
MedLine Citation:
PMID:  3103909     Owner:  NLM     Status:  MEDLINE    
Diploid human lymphoblast cells exhibit apparent saturation of mutation induced by exposure to aflatoxin B1, despite a linear increase in the amount and proportion of the aflatoxin-DNA adducts formed. The saturation is neither a cell cycle phenomenon nor a result of a genetically heterozygous population. Examination of the biphasic nature of aflatoxin-DNA adduct loss in vivo shows initial, rapid removal of all adduct species, followed by a slow loss of the aflatoxin-N7-guanine adduct alone. We hypothesize that these data reveal two modes of adduct loss in these cells. The first is an inducible, error-free system that is short-lived, turning off as adduct levels fall below the induction threshold of some 1000 total adducts/cell. The second loss is slower and results from spontaneous depurination of remaining aflatoxin-N7-guanines. Our data are in agreement with the possibility that apurinic sites thus generated are responsible for the mutation observed. A major paradox arises from the fact that aflatoxin-related premutagenic depurinations are estimated to be only 10% of the number of spontaneous depurinations estimated by others to occur in human cells in a 1-h period.
D A Kaden; K M Call; P M Leong; E A Komives; W G Thilly
Related Documents :
15131059 - Arsenic trioxide-induced death of neuroblastoma cells involves activation of bax and do...
8021299 - Both viral (adenovirus e1b) and cellular (hsp 70, p53) components interact with centros...
9247309 - Heat shock induces transient p53-dependent cell cycle arrest at g1/s.
10825139 - Efficient induction of cell death by adenoviruses requires binding of e1b55k and p53.
12573569 - The htlv-1 tax oncoprotein attenuates dna damage induced g1 arrest and enhances apoptos...
10656449 - In vitro adenoviral vector p53-mediated transduction and killing correlates with expres...
22360529 - De novo reestablishment of gap junctional intercellular communications during reprogram...
16196909 - Tiling a plane in a dynamical process and its applications to arrays of quantum dots, d...
19416749 - Characterization of endocytosis of transferrin-coated plga nanoparticles by the blood-b...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer research     Volume:  47     ISSN:  0008-5472     ISO Abbreviation:  Cancer Res.     Publication Date:  1987 Apr 
Date Detail:
Created Date:  1987-05-04     Completed Date:  1987-05-04     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1993-2001     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aflatoxin B1
Aflatoxins / metabolism,  toxicity*
Cell Cycle / drug effects
Cell Line
Cell Survival / drug effects
DNA / metabolism
DNA Repair / drug effects*
Lymphocytes / drug effects*
Time Factors
Grant Support
5-P01-ES00597/ES/NIEHS NIH HHS; 5-T32-ES07020-07/ES/NIEHS NIH HHS
Reg. No./Substance:
0/Aflatoxins; 1162-65-8/Aflatoxin B1; 9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chronic 12-O-tetradecanoylphorbol-13-acetate treatment prevents restoration of collagen loss associa...
Next Document:  N-glucuronidation of carcinogenic aromatic amines catalyzed by rat hepatic microsomal preparations a...